Advertisement

Medical Oncology

, 31:922 | Cite as

Stemness state regulators SALL4 and SOX2 are involved in progression and invasiveness of esophageal squamous cell carcinoma

  • Mohammad Mahdi Forghanifard
  • Sima Ardalan Khales
  • Afsaneh Javdani-Mallak
  • Abolfazl Rad
  • Moein Farshchian
  • Mohammad Reza AbbaszadeganEmail author
Original Paper

Abstract

Cancer stem cells, as a subgroup of tumor cells, resemble critical properties of embryonic stem cells (ESCs) such as self-renewal and maintenance of stemness state. SALL4 and SOX2 are two main transcription factors involving in maintenance of pluripotency, self-renewal and cell fate decision in ESCs. In this study, we aimed to elucidate the expression levels of these important transcription factors in esophageal squamous cell carcinoma (ESCC) and to reveal their probable roles in maintenance and progression of the disease. The expression level of SALL4 and SOX2 was analyzed in fresh tumoral tissues in comparison with distant tumor-free tissues of 50 ESCC patients by relative comparative real-time PCR. SALL4 and SOX2 were overexpressed in 64 and 32 % of tumor samples, respectively, in significant correlation with each other (p = 0.028). There was a significantly inverse correlation between low level of SALL4 expression and metastasis of tumor cells into the lymph nodes (p = 0.035). Furthermore, co-overexpression of the genes was significantly correlated with the depth of tumor invasion (p = 0.045) and metastasis to the lymph nodes (p = 0.049). SALL4 and SOX2 are co-overexpressed in ESCC and have a significant correlation with invasion and metastasis of the disease. To the best of our knowledge, this is the first report of SALL4 clinical relevance in ESCC to date. The clinical consequences of SALL4SOX2 association suggest a possible functional interaction between these factors in regulation of ESCC maintenance and aggressiveness and introduce these regulators of stemness state as potentially interesting therapeutic targets to bring new opportunities for onco-therapeutic modalities.

Keywords

SALL4 SOX2 Stemness state ESCC Cancer stem cell 

Notes

Acknowledgments

The authors gratefully acknowledge the colleagues from the departments of surgery and pathology at Omid Hospital and also the colleagues at the Division of Human Genetics for their help in gathering and preparing the tissue specimens.

Conflict of interest

The authors declare that they have no conflict of interests.

References

  1. 1.
    Frank NY, Schatton T, Frank MH. The therapeutic promise of the cancer stem cell concept. J Clin Invest. 2010;120(1):41–50.PubMedCentralPubMedCrossRefGoogle Scholar
  2. 2.
    He J, et al. Low-expression of microRNA-107 inhibits cell apoptosis in glioma by upregulation of SALL4. Int J Biochem Cell Biol. 2013;45(9):1962–73. Google Scholar
  3. 3.
    Yuri S, et al. Sall4 is essential for stabilization, but not for pluripotency, of embryonic stem cells by repressing aberrant trophectoderm gene expression. Stem Cells. 2009;27:796–805.PubMedCrossRefGoogle Scholar
  4. 4.
    Yang J, et al. A novel SALL4/OCT4 transcriptional feedback network for pluripotency of embryonic stem cells. PLoS One. 2010;5(5):e10766.Google Scholar
  5. 5.
    Yang J, Chai L, Fowles TC, Alipio Z, Xu D, Fink LM, Ward DC, Ma Y. Genome-wide analysis reveals Sall4 to be a major regulator of pluripotency in murine-embryonic stem cells. Proc Natl Acad Sci USA. 2008;105:19756–61.PubMedCentralPubMedCrossRefGoogle Scholar
  6. 6.
    Kobayashi D, et al. SALL4 is essential for cancer cell proliferation and is overexpressed at early clinical stages in breast cancer. Int J Oncol. 2011;38:933–9.PubMedGoogle Scholar
  7. 7.
    Forghanifard MM, et al. Role of SALL4 in the progression and metastasis of colorectal cancer. J Biomed Sci. 2013;20:6.PubMedCentralPubMedCrossRefGoogle Scholar
  8. 8.
    Oikawa T, et al. Sall4 regulates cell fate decision in fetal hepatic stem/progenitor cells. Gastroenterology. 2009;136(3):1000–11.PubMedCrossRefGoogle Scholar
  9. 9.
    Sinclair AH, Berta P, Palmer MS. A gene from the human sex determining region encodes a protein with homology to a conserved DNA-binding motif. Nature. 1990;346:240–4.PubMedCrossRefGoogle Scholar
  10. 10.
    Fong H, Hohenstein KA, Donovan PJ. Regulation of self-renewal and pluripotency by Sox2 in human embryonic stem cells. Stem Cells. 2008;26(8):1931–8.PubMedCrossRefGoogle Scholar
  11. 11.
    Patel M, Yang S. Advances in reprogramming somatic cells to induced pluripotent stem cells. Stem Cell Rev. 2010;6(3):367–80.PubMedCentralPubMedCrossRefGoogle Scholar
  12. 12.
    Laga AC, et al. Expression of the embryonic stem cell transcription factor SOX2 in human skin: relevance to melanocyte and Merkel cell biology. Am J Pathol. 2010;176(2):903–13.Google Scholar
  13. 13.
    Alonso MM, et al. Genetic and epigenetic modifications of Sox2 contribute to the invasive phenotype of malignant gliomas. PLoS One. 2011;6(11):e26740.PubMedCentralPubMedCrossRefGoogle Scholar
  14. 14.
    Li XL, et al. Expression of the SRY-related HMG box protein SOX2 in human gastric carcinoma. Int J Oncol. 2004;24(2):257–63.PubMedGoogle Scholar
  15. 15.
    Abd El-Maqsoud NM, Abd El-Rehim DM. Clinicopathologic implications of EpCAM and Sox2 expression in breast cancer. Clin Breast Cancer. 2014;14(1):e1–9.Google Scholar
  16. 16.
    Chen S, et al. SOX2 gene regulates the transcriptional network of oncogenes and affects tumorigenesis of human lung cancer cells. PLoS One. 2012;7(5):e36326.PubMedCentralPubMedCrossRefGoogle Scholar
  17. 17.
    Jia X, et al. SOX2 promotes tumorigenesis and increases the anti-apoptotic property of human prostate cancer cell. J Mol Cell Biol. 2011;3(4):230–8.PubMedCrossRefGoogle Scholar
  18. 18.
    Han X, et al. Silencing SOX2 induced mesenchymal–epithelial transition and its expression predicts liver and lymph node metastasis of CRC patients. PLoS One. 2012;7(8):e41335.PubMedCentralPubMedCrossRefGoogle Scholar
  19. 19.
    Girouard SD, et al. SOX2 contributes to melanoma cell invasion. Lab Invest. 2012;92(3):362–70.PubMedCrossRefGoogle Scholar
  20. 20.
    Sobin LH, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumours. London: Wiley; 2011.Google Scholar
  21. 21.
    Rubie C, et al. Housekeeping gene variability in normal and cancerous colorectal, pancreatic, esophageal, gastric and hepatic tissues. Mol Cell Probes. 2005;19(2):101–9.PubMedCrossRefGoogle Scholar
  22. 22.
    Bass AJ, et al. SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas. Nat Genet. 2009;41(11):1238–42. Google Scholar
  23. 23.
    Liu K, et al. Sox2 cooperates with inflammation-mediated Stat3 activation in the malignant transformation of foregut basal progenitor cells. Cell Stem Cell. 2013;12(3):304–15.PubMedCentralPubMedCrossRefGoogle Scholar
  24. 24.
    Ben-Porath I, et al. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet. 2008;40(5):499–507.PubMedCentralPubMedCrossRefGoogle Scholar
  25. 25.
    Mallanna SK, et al. Proteomic analysis of Sox2-associated proteins during early stages of mouse embryonic stem cell differentiation identifies Sox21 as a novel regulator of stem cell fate. Stem Cells. 2010;28(10):1715–27.PubMedCentralPubMedCrossRefGoogle Scholar
  26. 26.
    Hussenet T, Dali S, Exinger J, et al. SOX2 is an oncogene activated by recurrent 3q26.3 amplifications in human lung squamous cell carcinomas. PLoS One. 2010;5(1):e8960.PubMedCentralPubMedCrossRefGoogle Scholar
  27. 27.
    Bahl K, Saraya A, Sharma R. Increased levels of circulating and tissue mRNAs of Oct-4, Sox-2, Bmi-1 and Nanog is ESCC patients: potential tool for minimally invasive cancer diagnosis. Biomark Insights. 2012;7:27–37.PubMedCentralPubMedGoogle Scholar
  28. 28.
    Lu Y, et al. Evidence that SOX2 overexpression is oncogenic in the lung. PLoS One. 2010;5(6):e11022.PubMedCentralPubMedCrossRefGoogle Scholar
  29. 29.
    Chen Y, et al. The molecular mechanism governing the oncogenic potential of SOX2 in breast cancer. J Biol Chem. 2008;283(26):17969–78.PubMedCrossRefGoogle Scholar
  30. 30.
    Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663–76.PubMedCrossRefGoogle Scholar
  31. 31.
    Zhang J, et al. Sall4 modulates embryonic stem cell pluripotency and early embryonic development by the transcriptional regulation of Pou5f1. Nat Cell Biol. 2006;8(10):1114–23.PubMedCrossRefGoogle Scholar
  32. 32.
    Kidder BL, Palmer S, Knott JG. SWI/SNF-Brg1 regulates self-renewal and occupies core pluripotency-related genes in embryonic stem cells. Stem Cells. 2009;27(2):317–28.PubMedCrossRefGoogle Scholar
  33. 33.
    He XT, Cao XF, Ji L. Association between Bmi1 and clinicopathological status of esophageal squamous cell carcinoma. World J Gastroenterol. 2009;15(19):2389–94.PubMedCentralPubMedCrossRefGoogle Scholar
  34. 34.
    Van Raay TJ, et al. Frizzled 5 signaling governs the neural potential of progenitors in the developing Xenopus retina. Neuron. 2005;46(1):23–36.PubMedCrossRefGoogle Scholar
  35. 35.
    Moghbeli M, et al. Association of PYGO2 and EGFR in esophageal squamous cell carcinoma. Med Oncol. 2013;30(2):516.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Mohammad Mahdi Forghanifard
    • 1
  • Sima Ardalan Khales
    • 2
  • Afsaneh Javdani-Mallak
    • 2
  • Abolfazl Rad
    • 2
    • 3
  • Moein Farshchian
    • 4
  • Mohammad Reza Abbaszadegan
    • 2
    • 5
    Email author
  1. 1.Department of Biology, Damghan BranchIslamic Azad UniversityDamghanIslamic Republic of Iran
  2. 2.Division of Human Genetics, Immunology Research Center, Avicenna Research InstituteMashhad University of Medical SciencesMashhadIslamic Republic of Iran
  3. 3.Department of Biochemistry and Nutrition, Cellular and Molecular Research CenterSabzevar University of Medical SciencesSabzevarIslamic Republic of Iran
  4. 4.Department of Biology, Faculty of ScienceFerdowsi University of MashhadMashhadIslamic Republic of Iran
  5. 5.Medical Genetics Research Center, Medical SchoolMashhad University of Medical SciencesMashhadIslamic Republic of Iran

Personalised recommendations